Stock info Hikma Pharmaceuticals | Filter  Basic-Info

Hikma Pharmaceuticals

The past year was a good year for Hikma Pharmaceuticals investors

The stock lost over the past 12 months at around 19 percent. Over the past 5 years Hikma Pharmaceuticals' stock lost at around 0 percent in value.

The headquarter of Hikma Pharmaceuticals is based in London. Hikma Pharmaceuticals's core business is the pharmaceutical sector. Over the past 10 years the global pharmaceutical companies gained around 75 percent. As from 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.

The English company didn't pay out any dividends (in the past 5 years).

Hikma Pharmaceuticals financed with a quite low debt position

At the end of 2015 the pharmaceutical company's balance sheet equaled 0 million GBp. At the end of 2015 the total debt positon equaled 0 million GBp. This is around percent of the total balance sheet.

All the company's financial reports are available here. More information about Hikma Pharmaceuticals can be found it's website. .